Successful clearance of extensive/recalcitrant cutaneous warts by acitretin monotherapy: A case series study
- 1 May 2020
- journal article
- research article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (3), e13390
- https://doi.org/10.1111/dth.13390
Abstract
Most available options for the treatment of warts are limited by the potential for scarring, pain, lack of response, or recurrences, and the patients are often unable to tolerate and accept those experiences. The aim of this study was to evaluate the clinical efficacy and safety of oral systemic acitretin monotherapy in patients with extensive/recalcitrant cutaneous warts. The patients were given a dose of acitretin of 0.8 mg kg(-1) day(-1), and the clinical efficacy and safety of acitretin was assessed every 2 weeks for 2 months. A total of 14 patients (12 males and 2 females) were included, with an age of 14-60 years (mean 33 +/- 14.7 years) and a course of 4-48 months (mean 21.6 +/- 13.4 months). After 2 months of acitretin treatment, 42.9% (6/14) of patients (including warts of the feet, legs, and hands) exhibited complete response, 28.6% (4/14) excellent response, and 28.6% (4/14) good response. All patients demonstrated significant improvement, and the drug was well tolerated, with no patients discontinuing therapy due to side effects. Common mild side effects included dry skin and cheilitis. There were no recurrences during a follow-up period of 6 months. Acitretin monotherapy is an effective, safe, and well-tolerated treatment for patients with extensive/recalcitrant cutaneous warts who are unsuitable for or unwilling to accept traditional treatment methods.Funding Information
- The Medical and Health Technology Projects of Guangzhou (20171A011284)
- the Medical Science and Technology Research Foundation of Guangdong Province (A2017311)
- the Natural Science Foundation of Guangdong (2018A0303130011)
- The Science and Technology Program of Guangzhou (201904010191)
This publication has 42 references indexed in Scilit:
- Treatment of Plane Warts with a Low-Dose Oral IsotretinoinISRN Dermatology, 2012
- Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccineJournal of the European Academy of Dermatology and Venereology, 2010
- Acitretin revisited in the era of biologicsJournal of Dermatological Treatment, 2010
- Use of acitretin in the treatment of resistant viral wartsJournal of Dermatological Treatment, 2010
- Vitamin effects on the immune system: vitamins A and D take centre stageNature Reviews Immunology, 2008
- Effects of Topically Applied Acitretin in Reconstructed Human Epidermis and the Rhino MouseJournal of Investigative Dermatology, 2008
- Acitretin in the management of recalcitrant wartsIndian Journal of Dermatology, Venereology and Leprology, 2008
- Multiple huge cutaneous horns overlying verrucae vulgaris induced by human papillomavirus type 2: a case reportBritish Journal of Dermatology, 2007
- Treatment of extensive and recalcitrant viral warts with acitretinInternational Journal of Dermatology, 2006
- Duodenal ulcers that are difficult to treat.BMJ, 1989